Allergan fell$. 91 or. 4 percent, to $226.92. Baxter International Inc. fell$. 27 or. 4 percent, to $70.61. Boston Scientific Corp. fell$. 16 or 1.1 percent, to $14.80.» Read More
With stocks shrugging off the wall of worry in the first quarter, the second quarter could prove to be a less rewarding time for those long equity markets as central banks begin to tighten policy via rate hikes or withdrawing extraordinary measures.
The "Mad Money" host shares a few interesting spec plays in the health care space.